Anupam Rasayan India Limited

Anupam Rasayan India Limited

Anupam Rasayan India Limited has secured a six-year supply contract with a global industrial major for the supply of a specialty chemical product.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange about Copy of Newspaper Publication pertaining to Post Offer Advertisement for the acquisition of fully paid-up equity shares of Bliss GVS Pharma Limited.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange about Credit Rating. Crisil Ratings has continued its ratings on the bank facilities and non-convertible debentures of Anupam Rasayan India Limited.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has announced its Q1 FY27 earnings, with a 36% year-on-year growth in consolidated total income. The company has commercialized Ethyl Trifluoroacetate (ETFA) using flow chemistry, signed a Letter of Intent with BASQUEVOLT, and made progress on the proposed acquisition of Bliss GVS Pharma.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has submitted newspaper advertisement clippings pertaining to its unaudited financial results for the quarter ended June 30, 2026.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has submitted the audio recording of its earnings call for the quarter ended June 30, 2026, on its website.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange about Investor Presentation for Q1 FY27, showcasing strong growth of 36% in consolidated total income and 35% in consolidated EBITDA, with margins at 26%.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a 36% year-on-year growth in total revenue and a 35% year-on-year growth in EBITDA.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange regarding the appointment of Mr. Ravi Desai as Chief Operating Officer of the company, effective from August 14, 2026. Mr. Desai has over 20 years of experience in the speciality chemicals industry and has held leadership responsibilities in Sales and Marketing.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has submitted its standalone and consolidated financial results for the quarter ended June 30, 2026, and approved the appointment of Mr. Ravi Desai as Chief Operating Officer.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange regarding the allotment of 1,531 equity shares under the ESOP Scheme 2020.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has scheduled an earnings call on August 14, 2026, to discuss its unaudited financial results for the quarter ended June 30, 2026.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has submitted newspaper advertisement clippings for the Pre-Offer Advertisement and Corrigendum to the Detailed Public Statement for the Open Offer for acquisition of 26% stake in Bliss GVS Pharma Limited.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange about Letter of Offer regarding the open offer for acquisition of fully paid-up equity shares of Bliss GVS Pharma Limited from the Public Shareholders, by the Company together with PAC.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has submitted a copy of a newspaper publication regarding an addendum to the public announcement, detailed public statement, and draft letter of offer for the acquisition of a 26% stake in Bliss GVS Pharma Limited.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has acquired 100% of Mates Visa Consultancy Private Limited, an unlisted private company providing visa and passport consultancy services, for INR 10,000.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has signed a non-binding Letter of Intent (LOI) with BASQUEVOLT, S.A. to explore the potential supply of a specialty chemical product worth $300 Mn over a period of up to 10 years.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has received a confirmation certificate from MUFG Intime India Private Limited stating that Regulation 74(5) of SEBI (DP) Regulations, 2018 is not applicable to the company as all its shares are in dematerialized form and no requests for rematerialization were received during the quarter ended June 30, 2026.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from July 1, 2026, till the end of 48 hours after the declaration of the Unaudited Financial Results for the quarter ended June 30, 2026.